This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim Gmbh. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: C Wayne Smith: Innovator in Asthma Treatment
Introduction
C Wayne Smith is a notable inventor based in Sugarland, TX (US). He has made significant contributions to the field of medicine, particularly in the treatment of asthma. His innovative approach has led to the development of a unique patent that addresses a critical health issue.
Latest Patents
C Wayne Smith holds a patent for the "Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in a method for treating asthma in a patient using an agent selected from the group consisting of." This patent represents a significant advancement in asthma treatment, showcasing his commitment to improving patient care.
Career Highlights
C Wayne Smith is currently employed at Boehringer Ingelheim GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on developing innovative therapies that can enhance the quality of life for asthma patients.
Collaborations
Throughout his career, C Wayne Smith has collaborated with esteemed colleagues, including Robert H Gundel and Craig D Wegner. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of asthma treatment.
Conclusion
C Wayne Smith's contributions to asthma treatment through his patent and work at Boehringer Ingelheim GmbH highlight his dedication to innovation in healthcare. His efforts continue to pave the way for advancements that can significantly impact patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile